Daunorubicin for system suitability

Hazard statements (CLP)

H301, H315, H317, H319, H334, H335, H340, H350, H360FD

Code

Statements

H301

Toxic if swallowed

SECTION 2: Hazards identification

Adverse physicochemical, human health and environmental effects

Expert judgement and weight of evidence determination.

2.2 Label elements

Labelling

Hazard pictograms

GHS06 GHS08 GHS06 GHS08

Signal word

Danger

Contains

Daunorubicin hydrochloride; Doxorubicin hydrochloride

Hazard statements

H301 - Toxic if swallowed. H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 - May cause respiratory irritation. H340 - May cause genetic defects. H350 - May cause cancer. H360FD - May damage fertility. May damage the unborn child.

Precautionary statements

P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P271 - Use only outdoors or in a well-ventilated area. P272 - Contaminated work clothing should not be allowed out of the workplace. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P284 - Wear respiratory protection. P301+P310 - IF SWALLOWED: Immediately call a POISON CENTER or doctor. P302+P352 - IF ON SKIN: Wash with plenty of water. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308+P313 - IF exposed or concerned: Get medical advice/attention. P312 - Call a POISON CENTRE or doctor if you feel unwell. P321 - Specific treatment (see supplemental first aid instruction on this label). P330 - Rinse mouth. P332+P313 - If skin irritation occurs: Get medical advice/attention. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P337+P313 - If eye irritation persists: Get medical advice/attention. P342+P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor. P362+P364 - Take off contaminated clothing and wash it before reuse. P403+P233 - Store in a well-ventilated place. Keep container tightly closed. P405 - Store locked up. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation. Labelling according to: exemption for inner packaging where the contents do not exceed 10ml

Hazardous Ingredients

Daunorubicin hydrochloride; Doxorubicin hydrochloride

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %